Tonix Pharmaceuticals Holding earnings were -$130.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TNXP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$22.1M, up 55.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNXP reported annual earnings of -$130.0M, with 11.5% growth. The next TNXP earnings date is May 22, 2025.
Tonix Pharmaceuticals Holding Earnings Reports & History FAQ
What were Tonix Pharmaceuticals Holding's earnings last quarter?
On TNXP's earnings call on Invalid Date, Tonix Pharmaceuticals Holding (NASDAQ: TNXP) reported Q4 2024 earnings per share (EPS) of $289.40, up 177.54% year over year. Total TNXP earnings for the quarter were -$22.11 million. In the same quarter last year, Tonix Pharmaceuticals Holding's earnings per share (EPS) was -$373.25.
When does Tonix Pharmaceuticals Holding report earnings?
The next TNXP earnings date is Invalid Date. Add TNXP to your watchlist to be reminded of Tonix Pharmaceuticals Holding's next earnings date.
What was TNXP's earnings growth in the past year?
As of Tonix Pharmaceuticals Holding's earnings date in Invalid Date, Tonix Pharmaceuticals Holding's earnings has grown year over year. TNXP earnings in the past year totalled -$130.04 million.
Is Tonix Pharmaceuticals Holding profitable or losing money?
As of the last Tonix Pharmaceuticals Holding earnings report, Tonix Pharmaceuticals Holding is currently losing money. Tonix Pharmaceuticals Holding's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$130.04 million, a 11.47% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.